Shopping Cart
Remove All
Your shopping cart is currently empty
Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic derived from tetracycline that binds to the 30S ribosomal subunit, disrupting the binding of aminoacyl-tRNA to the mRNA-ribosome complex.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $32 | In Stock | In Stock | |
| 10 mg | $52 | In Stock | In Stock | |
| 25 mg | $72 | In Stock | In Stock | |
| 50 mg | $107 | In Stock | In Stock | |
| 100 mg | $171 | In Stock | In Stock | |
| 200 mg | $261 | In Stock | In Stock | |
| 500 mg | $439 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $54 | In Stock | In Stock |
| Description | Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic derived from tetracycline that binds to the 30S ribosomal subunit, disrupting the binding of aminoacyl-tRNA to the mRNA-ribosome complex. |
| Targets&IC50 | A. baumannii:2 mg/mL (MIC90), A. baumannii:1 mg/mL (MIC50), E. coli:125 ng/mL (Mean MIC) |
| In vitro | Tigecycline inhibited methicillin-resistant Staphylococcus aureus in a rabbit model of osteomyelitis. Tigecycline was shown to be resistant to Legionella pneumophila in guinea pigs with Legionella pneumophila pneumonia. |
| In vivo | Tigecycline, a substrate for the tetracycline-specific efflux pump, exhibits antibacterial activity against a wide range of aerobic and anaerobic bacteria. For enterococci, staphylococci and streptococci (MIC=0.06-0.25 mg / L), Tigecycline was able to produce bacteriostatic effects. |
| Synonyms | GAR-936 |
| Molecular Weight | 585.65 |
| Formula | C29H39N5O8 |
| Cas No. | 220620-09-7 |
| Smiles | O[C@]12[C@]([C@H](N(C)C)C(O)=C(C(N)=O)C1=O)(C[C@]3(C(=C2O)C(=O)C=4C(C3)=C(N(C)C)C=C(NC(CNC(C)(C)C)=O)C4O)[H])[H] |
| Relative Density. | 1.455 g/cm3 |
| Color | Orange |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 93 mg/mL (158.8 mM), Sonication is recommended. H2O: 92 mg/mL (157.09 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (5.63 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.